BECTON DICKINSON & CO - 8-K Filing
BD announces Michael D. Garrison's retirement effective October 2026; BioPharma Systems to report directly to CEO Tom Polen (Items: 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFI, 7.01 REGULATION FD DISCLOSUREOn July 22, 2026, BD issued a press release relating to the matters described above in Item 5, 9.01 FINANCIAL STATEMENTS AND EXHIBITS)
Tickers: $BDX